Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.09 USD | -3.06% | +3.40% | -25.46% |
Financials (USD)
Sales 2024 * | 397M | Sales 2025 * | 256M | Capitalization | 5.63B |
---|---|---|---|---|---|
Net income 2024 * | -456M | Net income 2025 * | -528M | EV / Sales 2024 * | 17 x |
Net Debt 2024 * | 1.1B | Net Debt 2025 * | 1.5B | EV / Sales 2025 * | 27.9 x |
P/E ratio 2024 * |
-11.4
x | P/E ratio 2025 * |
-10.3
x | Employees | 553 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.95% |
Latest transcript on BridgeBio Pharma, Inc.
1 day | -3.06% | ||
1 week | +3.40% | ||
Current month | +17.45% | ||
1 month | +20.46% | ||
3 months | -19.13% | ||
6 months | +2.87% | ||
Current year | -25.46% |
Managers | Title | Age | Since |
---|---|---|---|
Neil Kumar
FOU | Founder | 45 | 14-12-31 |
Charles Homcy
FOU | Founder | 75 | 14-12-31 |
Founder | 73 | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 16-02-29 |
Founder | 73 | 14-12-31 | |
Fred Hassan
BRD | Director/Board Member | 78 | 21-08-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.35% | 2 M€ | -.--% | ||
0.12% | 7 M€ | -.--% | - | |
0.11% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 30.09 | -3.06% | 2,247,140 |
24-05-16 | 31.04 | +3.57% | 2,156,881 |
24-05-15 | 29.97 | +3.52% | 1,442,425 |
24-05-14 | 28.95 | +1.58% | 1,024,852 |
24-05-13 | 28.5 | -2.06% | 1,875,002 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.46% | 5.63B | |
-2.32% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+58.05% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+3.75% | 8.79B |
- Stock Market
- Equities
- BBIO Stock